{"id":"NCT03370133","sponsor":"UCB Biopharma SRL","briefTitle":"A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis","officialTitle":"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-12-06","primaryCompletion":"2019-01-08","completion":"2019-12-13","firstPosted":"2017-12-12","resultsPosted":"2022-02-03","lastUpdate":"2024-01-05"},"enrollment":567,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Plaque Psoriasis","Moderate to Severe Chronic Plaque Psoriasis","Psoriatic Arthritis"],"interventions":[{"type":"DRUG","name":"Bimekizumab","otherNames":["UCB4940"]},{"type":"DRUG","name":"Ustekinumab","otherNames":["StelaraÂ®"]},{"type":"OTHER","name":"Placebo","otherNames":["PBO"]}],"arms":[{"label":"Bimekizumab cohort","type":"EXPERIMENTAL"},{"label":"Ustekinumab cohort","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a study to compare the efficacy of bimekizumab versus placebo and an active comparator in the treatment of subjects with moderate to severe chronic plaque psoriasis (PSO).","primaryOutcome":{"measure":"Percentage of Participants With a Psoriasis Area and Severity Index 90 (PASI90) Response at Week 16","timeFrame":"Week 16","effectByArm":[{"arm":"Placebo (RS)","deltaMin":4.8,"sd":null},{"arm":"Bimekizumab 320 mg Q4W (RS)","deltaMin":85,"sd":null},{"arm":"Ustekinumab (RS)","deltaMin":49.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG001 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":7},"locations":{"siteCount":105,"countries":["United States","Australia","Belgium","Canada","Germany","Hungary","Italy","Japan","Poland","Russia","United Kingdom"]},"refs":{"pmids":["36648594","35544084","37950894","40886218","39578348","36751950","34260044","33549193"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":83},"commonTop":["Nasopharyngitis","Oral candidiasis","Upper respiratory tract infection","Headache","Hypertension"]}}